Plain-English translation of NCT06577467 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers know that pieces of the COVID-19 virus can remain in your body even after you've recovered from the acute infection. This study is trying to understand whether these viral remnants might be playing a role in long-term complications, particularly neurological symptoms like brain fog, fatigue, and pain that some people experience months after COVID-19. The study will collect tissue samples from people with ongoing neurological symptoms and compare them to people who fully recovered.
Many people experience persistent brain and nervous system problems long after their initial COVID-19 infection, but doctors don't yet understand why this happens. This medication may help reveal whether leftover viral particles in the body are contributing to these long-term symptoms, which could eventually lead to better treatments.
You likely qualify if…
You likely don't qualify if…
You would visit the National Institutes of Health Clinical Center to have tissue samples collected from multiple sites in your body. The study is designed to be relatively brief and focused on gathering these samples so researchers can examine them in detail under a microscope and with laboratory tests. Your samples would help scientists understand whether viral remnants are present in people with lingering symptoms compared to those who fully recovered.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States